These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11328534)

  • 1. TP53 deleted cells in de novo glioblastomas using fluorescence in situ hybridization.
    Horiguchi H; Sano T; Hirose T
    Pathol Int; 2001 Mar; 51(3):187-92. PubMed ID: 11328534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme.
    Kraus JA; Glesmann N; Beck M; Krex D; Klockgether T; Schackert G; Schlegel U
    J Neurooncol; 2000 Jun; 48(2):89-94. PubMed ID: 11083071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors.
    Cheng Y; Ng HK; Ding M; Zhang SF; Pang JC; Lo KW
    J Neuropathol Exp Neurol; 1999 Feb; 58(2):120-8. PubMed ID: 10029095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics of radiographically defined de novo glioblastoma multiforme.
    Tortosa A; Ino Y; Odell N; Swilley S; Sasaki H; Louis DN; Henson JW
    Neuropathol Appl Neurobiol; 2000 Dec; 26(6):544-52. PubMed ID: 11123721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supratentorial glioblastoma in adults: identification of subsets and their clinical correlation.
    Sarkar C; Sinha S; Sharma MC; Kumar R; Mehta VS
    Brain Tumor Pathol; 2004; 21(1):7-12. PubMed ID: 15696962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric glioblastomas: a histopathological and molecular genetic study.
    Suri V; Das P; Pathak P; Jain A; Sharma MC; Borkar SA; Suri A; Gupta D; Sarkar C
    Neuro Oncol; 2009 Jun; 11(3):274-80. PubMed ID: 18981259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 gene mutations, nuclear p53 accumulation, expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme.
    Kraus JA; Wenghoefer M; Glesmann N; Mohr S; Beck M; Schmidt MC; Schröder R; Berweiler U; Roggendorf W; Diete S; Dietzmann K; Heuser K; Müller B; Fimmers R; von Deimling A; Schlegel U
    J Neurooncol; 2001 May; 52(3):263-72. PubMed ID: 11519857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic relevance of TP53 mutations, p53 protein, Ki-67 index and conventional histological grading in oligodendrogliomas.
    Hagel C; Krog B; Laas R; Stavrou DK
    J Exp Clin Cancer Res; 1999 Sep; 18(3):305-9. PubMed ID: 10606174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of chromosome 17 aneuplody and TP53 gene deletion in a broad variety of solid tumors by dual-color fluorescence in situ hybridization (FISH)].
    Herrera JC; Isaza LF; Ramírez JL; Vásquez G; Muñetón CM
    Biomedica; 2010; 30(3):390-400. PubMed ID: 21713341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting the role of p53 in primary and secondary glioblastomas.
    Nagpal J; Jamoona A; Gulati ND; Mohan A; Braun A; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2006; 26(6C):4633-9. PubMed ID: 17214319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 mutations versus EGF receptor expression in giant cell glioblastomas.
    Peraud A; Watanabe K; Plate KH; Yonekawa Y; Kleihues P; Ohgaki H
    J Neuropathol Exp Neurol; 1997 Nov; 56(11):1236-41. PubMed ID: 9370234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification and overexpression of epidermal growth factor receptor gene in glioblastomas of Chinese patients correlates with patient's age but not with tumor's clinicopathological pathway.
    Xie D; Zeng YX; Wang HJ; Tai LS; Wen JM; Tao Y; Ma NF; Hu L; Sham JS; Guan XY
    Acta Neuropathol; 2005 Nov; 110(5):481-9. PubMed ID: 16151725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
    Ständer M; Peraud A; Leroch B; Kreth FW
    Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
    Peraud A; Kreth FW; Wiestler OD; Kleihues P; Reulen HJ
    Clin Cancer Res; 2002 May; 8(5):1117-24. PubMed ID: 12006527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant nuclear p53 protein expression detected by immunohistochemistry is associated with hemizygous P53 deletion and poor survival for multiple myeloma.
    Chang H; Yeung J; Qi C; Xu W
    Br J Haematol; 2007 Aug; 138(3):324-9. PubMed ID: 17555471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of glioblastomas in young adults.
    Kleinschmidt-DeMasters BK; Meltesen L; McGavran L; Lillehei KO
    Brain Pathol; 2006 Oct; 16(4):273-86. PubMed ID: 17107596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features.
    Benito R; Gil-Benso R; Quilis V; Perez M; Gregori-Romero M; Roldan P; Gonzalez-Darder J; Cerdá-Nicolas M; Lopez-Gines C
    Neuropathology; 2010 Aug; 30(4):392-400. PubMed ID: 20051017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic relevance of p53 protein expression in glioblastoma.
    Birner P; Piribauer M; Fischer I; Gatterbauer B; Marosi C; Ungersböck K; Rössler K; Budka H; Hainfellner JA
    Oncol Rep; 2002; 9(4):703-7. PubMed ID: 12066196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection.
    Shinoda J; Sakai N; Murase S; Yano H; Matsuhisa T; Funakoshi T
    J Neurooncol; 2001 Apr; 52(2):161-71. PubMed ID: 11508816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of p53 immunoreactivity in adult patients with supratentorial fibrillary astrocytic neoplasms.
    Montine TJ; Bruner JM; Vandersteenhoven JJ; Dodge RK; Burger PC
    Diagn Mol Pathol; 1994 Dec; 3(4):240-5. PubMed ID: 7866633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.